Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition

Honorine Lebraud1, Richard A Noble2, Nicole Phillips2

  • 1Astex Pharmaceuticals , 436 Cambridge Science Park , Cambridge CB4 0QA , United Kingdom.

Insights

Researchers developed RG7388-TCO, a novel molecule targeting MDM2, a key regulator of the p53 tumor suppressor. This tool allows for precise imaging and assessment of MDM2 engagement in cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Chemical Biology

Background:

  • MDM2 is a critical negative regulator of the p53 tumor suppressor protein.
  • MDM2 inhibition is a therapeutic strategy for TP53 wild-type tumors.
  • RG7388 is a small molecule inhibitor of MDM2-p53 binding in clinical development.

Purpose of the Study:

  • To design, synthesize, and evaluate RG7388-TCO, a trans-cyclooctene tagged derivative of RG7388.
  • To utilize RG7388-TCO for imaging endogenous MDM2 in cancer cells.
  • To assess RG7388-TCO's utility in evaluating MDM2-p53 antagonism.

Main Methods:

  • Synthesis of RG7388-TCO, a functionalized MDM2 inhibitor.
  • Bioorthogonal chemistry: click reaction between trans-cyclooctene (TCO) and tetrazine.
  • Fluorescence imaging of endogenous MDM2 using tetrazine-BODIPY dye.
  • Affinity pull-down assay using tetrazine-agarose beads.

Main Results:

  • RG7388-TCO demonstrated high cellular potency and specificity for MDM2.
  • Successful in-cell fluorescence imaging of endogenous MDM2 in SJSA-1 and T778 tumor cells.
  • RG7388-TCO enabled pull-down of MDM2 from cell lysates.
  • The compound facilitates assessment of target engagement and MDM2-p53 antagonism.

Conclusions:

  • RG7388-TCO is a valuable chemical biology tool for MDM2 research.
  • This derivative enables precise visualization and quantification of MDM2 activity in vitro.
  • RG7388-TCO supports the development of MDM2-targeted cancer therapies.

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.7K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
Dynamic Equilibrium02:20

Dynamic Equilibrium

A reversible chemical reaction represents a chemical process that proceeds in both forward (left to right) and reverse (right to left) directions. When the rates of the forward and reverse reactions are equal, the concentrations of the reactant and product species remain constant over time and the system is at equilibrium. A special double arrow is used to emphasize the reversible nature of the reaction. The relative concentrations of reactants and products in equilibrium systems vary greatly;...
63.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Responses to Gravity and Touch02:26

Responses to Gravity and Touch

Gravitropism: Plant Responses to Gravity
42.0K